Alkaptonuria

Inherited biallelic mutations in the HGD gene causing enzyme deficiency.

Onset of HGA accumulation begins at birth but clinical symptoms appear after years of deposition.

No external triggers; disease progression is due to endogenous metabolic defect.

Progressive oxidation of HGA leads to tissue pigmentation and damage over time.

Secondary joint stress and wear may exacerbate symptoms but do not initiate disease.

Symptom onset typically occurs after decades of asymptomatic HGA accumulation.

Clinical manifestations usually appear in the 3rd to 5th decade of life.

Ochronotic pigmentation may be visible in urine from infancy but is often unnoticed.

Joint and connective tissue symptoms develop slowly over 10-20 years.

Cardiac and renal complications manifest in late adulthood after prolonged pigment deposition.

Early symptoms such as dark urine are often overlooked or misattributed to benign causes.

Lack of awareness leads to misdiagnosis as osteoarthritis or other arthropathies.

Ochronotic pigmentation in cartilage and sclera may be missed without careful examination.

Biochemical testing for elevated urinary HGA is not routinely performed early.

Genetic testing for HGD mutations is underutilized in patients with suggestive symptoms.

Dark urine from birth or early childhood due to homogentisic acid accumulation

Progressive joint pain and stiffness typically beginning in the third to fourth decade

Bluish-black discoloration of sclera, ear cartilage, and skin over pressure areas

Early-onset degenerative arthritis affecting spine, hips, and knees

Cardiac valve calcification leading to murmurs or heart failure in advanced disease

Patients report darkening of urine upon standing since childhood, often unnoticed.

Progressive joint pain and stiffness, especially in the spine, hips, and knees, begin in middle age.

Development of blue-black pigmentation of ear cartilage, sclera, and skin over time.

Symptoms of early-onset degenerative arthritis with decreased range of motion and joint swelling.

Possible history of cardiac valve disease or renal stones in advanced disease stages.

No prior acute illnesses directly cause alkaptonuria but history may include early-onset osteoarthritis.

Possible history of recurrent renal stones due to HGA deposition.

No specific medication exposures alter disease course but antioxidant therapy may be attempted.

No prior surgeries unless related to joint replacement for ochronotic arthropathy.

Family history often reveals undiagnosed relatives with similar symptoms.

Positive for autosomal recessive inheritance with affected siblings or consanguineous parents.

Relatives may have history of dark urine, early arthritis, or ochronosis.

Carrier parents are typically asymptomatic but can pass on biallelic HGD mutations.

Family members may have undergone joint replacements or have cardiac complications related to ochronosis.

Genetic counseling is important due to heritable nature of the disorder.

Bluish-black pigmentation of the sclera and ear cartilage due to homogentisic acid deposition

Darkening of urine upon standing or exposure to air from oxidation of homogentisic acid

Ochronotic pigmentation of connective tissues including skin, tendons, and cartilage

Restricted joint mobility and stiffness, especially in the spine and large joints

Degenerative arthritis signs such as joint swelling and tenderness in affected areas

Low-protein diet to reduce phenylalanine and tyrosine intake and decrease homogentisic acid accumulation

Physical therapy to maintain joint mobility and reduce stiffness

Surgical joint replacement for severe ochronotic arthropathy